These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20420125)

  • 1. Clinical immunological and immunogenetical aspects of neurological diseases.
    Péterfalvi A
    Ideggyogy Sz; 2010 Jan; 63(1-2):52-60. PubMed ID: 20420125
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple sclerosis and the CTLA4 autoimmunity polymorphism CT60: no association in patients from Germany, Hungary and Poland.
    Greve B; Simonenko R; Illes Z; Peterfalvi A; Hamdi N; Mycko MP; Selmaj KW; Rozsa C; Rajczy K; Bauer P; Berger K; Weissert R
    Mult Scler; 2008 Mar; 14(2):153-8. PubMed ID: 17942509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoregulation of autoimmunity by natural killer T cells.
    Linsen L; Somers V; Stinissen P
    Hum Immunol; 2005 Dec; 66(12):1193-202. PubMed ID: 16690406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunology of multiple sclerosis.
    Oger J; Roos R; Antel JP
    Neurol Clin; 1983 Aug; 1(3):655-79. PubMed ID: 6209537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunological abnormalities in multiple sclerosis].
    Tabira T
    No To Shinkei; 1983 Jun; 35(6):535-41. PubMed ID: 6194805
    [No Abstract]   [Full Text] [Related]  

  • 6. [Indicators of cellular immunity in patients with multiple sclerosis].
    Dziuba AN; Frolov VM; Gaĭdash IS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(2):12-4. PubMed ID: 1326155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A PD-1 polymorphism is associated with disease progression in multiple sclerosis.
    Kroner A; Mehling M; Hemmer B; Rieckmann P; Toyka KV; Mäurer M; Wiendl H
    Ann Neurol; 2005 Jul; 58(1):50-7. PubMed ID: 15912506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTLA-4 and multiple sclerosis: the A49G single nucleotide polymorphism shows no association with multiple sclerosis in a Southern Australian population.
    Wray BN; Stankovich J; Whittock L; Dwyer T; Ponsonby AL; van der Mei IA; Taylor B; Dickinson J; Foote S; McMorran BJ
    J Neuroimmunol; 2008 May; 196(1-2):139-42. PubMed ID: 18378005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do natural killer cells accelerate or prevent autoimmunity in multiple sclerosis?
    Lünemann JD; Münz C
    Brain; 2008 Jul; 131(Pt 7):1681-3. PubMed ID: 18586760
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression of Fas antigen on T cell subpopulations in peripheral blood of patients with relapsing-remitting multiple sclerosis.
    Bilińska M; Frydecka I; Podemski R; Teodorowska R; Gruszka E
    Med Sci Monit; 2001; 7(2):251-5. PubMed ID: 11257731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of interleukin 2 receptor and class II histocompatibility antigens on lymphocytes of the cerebrospinal fluid in patients with multiple sclerosis and other neurological diseases].
    Tournier-Lasserve E; Lyon-Caen O; Roullet E; Bach MA
    Pathol Biol (Paris); 1987 Mar; 35(3):303-6. PubMed ID: 3108835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reciprocal regulation between natural killer cells and autoreactive T cells.
    Shi FD; Van Kaer L
    Nat Rev Immunol; 2006 Oct; 6(10):751-60. PubMed ID: 16998508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical immunological studies of disseminated sclerosis].
    Matveeva TV; D'iakonova IN; Pille ER
    Sov Med; 1981; (4):22-7. PubMed ID: 6974897
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunoregulation and autoimmunity].
    Bach JF
    J Soc Biol; 2002; 196(4):255-8. PubMed ID: 12645290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate immune-mediated neuronal injury consequent to loss of astrocytes.
    Darlington PJ; Podjaski C; Horn KE; Costantino S; Blain M; Saikali P; Chen Z; Baker KA; Newcombe J; Freedman M; Wiseman PW; Bar-Or A; Kennedy TE; Antel JP
    J Neuropathol Exp Neurol; 2008 Jun; 67(6):590-9. PubMed ID: 18520777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The lymphocyte abnormality in CNS disease].
    Matsubara H; Igata A
    No To Shinkei; 1983 May; 35(5):423-31. PubMed ID: 6354216
    [No Abstract]   [Full Text] [Related]  

  • 17. The regulatory role of natural killer cells in multiple sclerosis.
    Takahashi K; Aranami T; Endoh M; Miyake S; Yamamura T
    Brain; 2004 Sep; 127(Pt 9):1917-27. PubMed ID: 15229129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3'UTR C2370A allele of the IL-23 receptor gene is associated with relapsing-remitting multiple sclerosis.
    Illes Z; Safrany E; Peterfalvi A; Magyari L; Farago B; Pozsonyi E; Rozsa C; Komoly S; Melegh B
    Neurosci Lett; 2008 Jan; 431(1):36-8. PubMed ID: 18180107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate immunity modulates autoimmunity: type 1 interferon-beta treatment in multiple sclerosis promotes growth and function of regulatory invariant natural killer T cells through dendritic cell maturation.
    Gigli G; Caielli S; Cutuli D; Falcone M
    Immunology; 2007 Nov; 122(3):409-17. PubMed ID: 17617156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of innate immunity in autoimmunity.
    Bach JF; Bendelac A; Brenner MB; Cantor H; De Libero G; Kronenberg M; Lanier LL; Raulet DH; Shlomchik MJ; von Herrath MG
    J Exp Med; 2004 Dec; 200(12):1527-31. PubMed ID: 15611284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.